<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910717-0023</DOCNO><DOCID>910717-0023.</DOCID><HL>   Business Brief -- C.R. Bard Inc.:   Health-Care Product Firm   Posts 43% Rise in Earnings</HL><DATE>07/17/91</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><CO>   BCR</CO><MS>CONSUMER NON-CYCLICAL (NCY)</MS><IN>EARNINGS (ERN)MEDICAL SUPPLIES, EYEGLASS MANUFACTURERS (MDS)</IN><NS>EARNINGS (ERN)</NS><RE>NEW JERSEY (NJ)NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   C.R. Bard Inc. posted sharply higher second-quarterearnings, reflecting the health-care product maker's improvedperformance in the urological and surgical markets.   Bard, based in Murray Hill, N.J., reported net income of$14.4 million, or 27 cents a share, up 43% from $10.1million, or 19 cents a share, a year earlier. Sales climbed13% to $218.7 million from $194.1 million.</LP><TEXT>   A spokesman said Bard's performance was also helped by thefirm's re-entry into the U.S. market for balloon angioplastycatheters. In a statement, however, the company saidsignificant benefits wouldn't be seen until later this year.   The company, which recalled its balloon catheters in 1989and 1990 over regulatory issues, received approval in Aprilfrom the Food and Drug Administration to put one model backon the market. At the time, the company said it would seekapproval for several more models.   For the first half, Bard posted a 45% profit rise to $28million, or 53 cents a share, from $19.3 million, or 36 centsa share. Sales advanced 11% to $430.2 million from $389.3million.</TEXT></DOC>